BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang K, Chen H, Zhou Z, Zhang H, Zhou HJ, Min W. ATPIF1 maintains normal mitochondrial structure which is impaired by CCM3 deficiency in endothelial cells. Cell Biosci 2021;11:11. [PMID: 33422124 DOI: 10.1186/s13578-020-00514-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhong G, Wang Q, Wang Y, Guo Y, Xu M, Guan Y, Zhang X, Wu M, Xu Z, Zhao W, Lian H, Wang H, Ye J. scRNA-seq reveals ATPIF1 activity in control of T cell antitumor activity. OncoImmunology 2022;11:2114740. [DOI: 10.1080/2162402x.2022.2114740] [Reference Citation Analysis]
2 Qin L, Zhang H, Li B, Jiang Q, Lopez F, Min W, Zhou JH. CCM3 Loss-Induced Lymphatic Defect Is Mediated by the Augmented VEGFR3-ERK1/2 Signaling. Arterioscler Thromb Vasc Biol 2021;41:2943-60. [PMID: 34670407 DOI: 10.1161/ATVBAHA.121.316707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]